nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclopentolate—CHRM3—epilepsy syndrome	0.251	0.389	CbGaD
Cyclopentolate—CHRM1—epilepsy syndrome	0.234	0.363	CbGaD
Cyclopentolate—BCHE—epilepsy syndrome	0.159	0.247	CbGaD
Cyclopentolate—Diphenhydramine—Phenytoin—epilepsy syndrome	0.121	1	CrCrCtD
Cyclopentolate—Drowsiness—Phenytoin—epilepsy syndrome	0.000344	0.00221	CcSEcCtD
Cyclopentolate—Dry mouth—Lacosamide—epilepsy syndrome	0.000343	0.00221	CcSEcCtD
Cyclopentolate—Desvenlafaxine—SLC6A4—epilepsy syndrome	0.000341	0.0603	CrCbGaD
Cyclopentolate—Lacrimation increased—Topiramate—epilepsy syndrome	0.000341	0.00219	CcSEcCtD
Cyclopentolate—Hallucination—Diazepam—epilepsy syndrome	0.000339	0.00218	CcSEcCtD
Cyclopentolate—Conjunctivitis—Phenytoin—epilepsy syndrome	0.000334	0.00215	CcSEcCtD
Cyclopentolate—Gastroenteritis—Pregabalin—epilepsy syndrome	0.000334	0.00215	CcSEcCtD
Cyclopentolate—Dry mouth—Clobazam—epilepsy syndrome	0.000333	0.00214	CcSEcCtD
Cyclopentolate—Disorientation—Pregabalin—epilepsy syndrome	0.000331	0.00213	CcSEcCtD
Cyclopentolate—Drowsiness—Carbamazepine—epilepsy syndrome	0.000328	0.00211	CcSEcCtD
Cyclopentolate—Hallucination—Felbamate—epilepsy syndrome	0.000328	0.00211	CcSEcCtD
Cyclopentolate—Agitation—Acetazolamide—epilepsy syndrome	0.000328	0.00211	CcSEcCtD
Cyclopentolate—Hyperkinesia—Gabapentin—epilepsy syndrome	0.000326	0.00209	CcSEcCtD
Cyclopentolate—Somnolence—Phenobarbital—epilepsy syndrome	0.000325	0.00209	CcSEcCtD
Cyclopentolate—Hallucination—Zonisamide—epilepsy syndrome	0.000321	0.00206	CcSEcCtD
Cyclopentolate—Coordination abnormal—Topiramate—epilepsy syndrome	0.00032	0.00206	CcSEcCtD
Cyclopentolate—Psychotic disorder—Valproic Acid—epilepsy syndrome	0.00032	0.00205	CcSEcCtD
Cyclopentolate—Conjunctivitis—Carbamazepine—epilepsy syndrome	0.000319	0.00205	CcSEcCtD
Cyclopentolate—Somnolence—Rufinamide—epilepsy syndrome	0.000319	0.00205	CcSEcCtD
Cyclopentolate—Drowsiness—Lamotrigine—epilepsy syndrome	0.000317	0.00204	CcSEcCtD
Cyclopentolate—Tremor—Propofol—epilepsy syndrome	0.00031	0.00199	CcSEcCtD
Cyclopentolate—Hallucination—Clonazepam—epilepsy syndrome	0.000309	0.00199	CcSEcCtD
Cyclopentolate—Convulsion—Acetazolamide—epilepsy syndrome	0.000309	0.00199	CcSEcCtD
Cyclopentolate—Conjunctivitis—Lamotrigine—epilepsy syndrome	0.000308	0.00198	CcSEcCtD
Cyclopentolate—Ataxia—Valproic Acid—epilepsy syndrome	0.000308	0.00198	CcSEcCtD
Cyclopentolate—Rash—Amobarbital—epilepsy syndrome	0.000307	0.00197	CcSEcCtD
Cyclopentolate—Dermatitis—Amobarbital—epilepsy syndrome	0.000306	0.00197	CcSEcCtD
Cyclopentolate—Gastroenteritis—Gabapentin—epilepsy syndrome	0.000306	0.00197	CcSEcCtD
Cyclopentolate—Flushing—Felbamate—epilepsy syndrome	0.000306	0.00197	CcSEcCtD
Cyclopentolate—Vision blurred—Midazolam—epilepsy syndrome	0.000305	0.00196	CcSEcCtD
Cyclopentolate—Agitation—Propofol—epilepsy syndrome	0.000304	0.00196	CcSEcCtD
Cyclopentolate—Tremor—Midazolam—epilepsy syndrome	0.000304	0.00195	CcSEcCtD
Cyclopentolate—Disorientation—Gabapentin—epilepsy syndrome	0.000303	0.00195	CcSEcCtD
Cyclopentolate—Vision blurred—Levetiracetam—epilepsy syndrome	0.000302	0.00194	CcSEcCtD
Cyclopentolate—Tremor—Levetiracetam—epilepsy syndrome	0.0003	0.00193	CcSEcCtD
Cyclopentolate—Somnolence—Lacosamide—epilepsy syndrome	0.000299	0.00192	CcSEcCtD
Cyclopentolate—Agitation—Midazolam—epilepsy syndrome	0.000298	0.00191	CcSEcCtD
Cyclopentolate—Rash—Primidone—epilepsy syndrome	0.000295	0.0019	CcSEcCtD
Cyclopentolate—Photophobia—Topiramate—epilepsy syndrome	0.000295	0.0019	CcSEcCtD
Cyclopentolate—Dermatitis—Primidone—epilepsy syndrome	0.000295	0.0019	CcSEcCtD
Cyclopentolate—Pethidine—GRIN2A—epilepsy syndrome	0.000294	0.052	CrCbGaD
Cyclopentolate—Agitation—Levetiracetam—epilepsy syndrome	0.000294	0.00189	CcSEcCtD
Cyclopentolate—Hallucination—Carbamazepine—epilepsy syndrome	0.000293	0.00189	CcSEcCtD
Cyclopentolate—Pruritus—Trimethadione—epilepsy syndrome	0.000292	0.00187	CcSEcCtD
Cyclopentolate—Vertigo—Midazolam—epilepsy syndrome	0.000291	0.00187	CcSEcCtD
Cyclopentolate—Hyoscyamine—CHRM3—epilepsy syndrome	0.00029	0.0513	CrCbGaD
Cyclopentolate—Somnolence—Clobazam—epilepsy syndrome	0.00029	0.00187	CcSEcCtD
Cyclopentolate—Tremor—Fosphenytoin—epilepsy syndrome	0.000289	0.00186	CcSEcCtD
Cyclopentolate—Psychotic disorder—Pregabalin—epilepsy syndrome	0.000289	0.00186	CcSEcCtD
Cyclopentolate—Flushing—Clonazepam—epilepsy syndrome	0.000289	0.00185	CcSEcCtD
Cyclopentolate—Vertigo—Levetiracetam—epilepsy syndrome	0.000288	0.00185	CcSEcCtD
Cyclopentolate—Convulsion—Propofol—epilepsy syndrome	0.000287	0.00184	CcSEcCtD
Cyclopentolate—Flushing—Oxcarbazepine—epilepsy syndrome	0.000285	0.00183	CcSEcCtD
Cyclopentolate—Agitation—Fosphenytoin—epilepsy syndrome	0.000284	0.00182	CcSEcCtD
Cyclopentolate—Vision blurred—Vigabatrin—epilepsy syndrome	0.000284	0.00182	CcSEcCtD
Cyclopentolate—Hallucination—Lamotrigine—epilepsy syndrome	0.000283	0.00182	CcSEcCtD
Cyclopentolate—Tremor—Vigabatrin—epilepsy syndrome	0.000282	0.00181	CcSEcCtD
Cyclopentolate—Urinary retention—Pregabalin—epilepsy syndrome	0.000281	0.00181	CcSEcCtD
Cyclopentolate—Vision blurred—Diazepam—epilepsy syndrome	0.000279	0.0018	CcSEcCtD
Cyclopentolate—Ataxia—Pregabalin—epilepsy syndrome	0.000278	0.00179	CcSEcCtD
Cyclopentolate—Vertigo—Fosphenytoin—epilepsy syndrome	0.000277	0.00178	CcSEcCtD
Cyclopentolate—Convulsion—Levetiracetam—epilepsy syndrome	0.000277	0.00178	CcSEcCtD
Cyclopentolate—Agitation—Vigabatrin—epilepsy syndrome	0.000277	0.00178	CcSEcCtD
Cyclopentolate—Dry mouth—Propofol—epilepsy syndrome	0.000276	0.00177	CcSEcCtD
Cyclopentolate—Hyperkinesia—Topiramate—epilepsy syndrome	0.000274	0.00176	CcSEcCtD
Cyclopentolate—Homatropine Methylbromide—CHRM3—epilepsy syndrome	0.000274	0.0484	CrCbGaD
Cyclopentolate—Flushing—Carbamazepine—epilepsy syndrome	0.000274	0.00176	CcSEcCtD
Cyclopentolate—Agitation—Diazepam—epilepsy syndrome	0.000272	0.00175	CcSEcCtD
Cyclopentolate—Hyoscyamine—CHRM1—epilepsy syndrome	0.000271	0.0478	CrCbGaD
Cyclopentolate—Vertigo—Vigabatrin—epilepsy syndrome	0.00027	0.00174	CcSEcCtD
Cyclopentolate—Dry mouth—Midazolam—epilepsy syndrome	0.00027	0.00173	CcSEcCtD
Cyclopentolate—Tremor—Felbamate—epilepsy syndrome	0.000269	0.00173	CcSEcCtD
Cyclopentolate—Convulsion—Fosphenytoin—epilepsy syndrome	0.000268	0.00172	CcSEcCtD
Cyclopentolate—Vertigo—Diazepam—epilepsy syndrome	0.000266	0.00171	CcSEcCtD
Cyclopentolate—Psychotic disorder—Gabapentin—epilepsy syndrome	0.000265	0.0017	CcSEcCtD
Cyclopentolate—Flushing—Lamotrigine—epilepsy syndrome	0.000264	0.0017	CcSEcCtD
Cyclopentolate—Tachycardia—Propofol—epilepsy syndrome	0.000264	0.0017	CcSEcCtD
Cyclopentolate—Agitation—Felbamate—epilepsy syndrome	0.000264	0.00169	CcSEcCtD
Cyclopentolate—Tremor—Zonisamide—epilepsy syndrome	0.000263	0.00169	CcSEcCtD
Cyclopentolate—Convulsion—Vigabatrin—epilepsy syndrome	0.000261	0.00168	CcSEcCtD
Cyclopentolate—Rash—Trimethadione—epilepsy syndrome	0.00026	0.00167	CcSEcCtD
Cyclopentolate—Dermatitis—Trimethadione—epilepsy syndrome	0.00026	0.00167	CcSEcCtD
Cyclopentolate—Somnolence—Acetazolamide—epilepsy syndrome	0.000259	0.00166	CcSEcCtD
Cyclopentolate—Tachycardia—Midazolam—epilepsy syndrome	0.000258	0.00166	CcSEcCtD
Cyclopentolate—Agitation—Zonisamide—epilepsy syndrome	0.000258	0.00166	CcSEcCtD
Cyclopentolate—Urinary retention—Gabapentin—epilepsy syndrome	0.000258	0.00166	CcSEcCtD
Cyclopentolate—Gastroenteritis—Topiramate—epilepsy syndrome	0.000257	0.00166	CcSEcCtD
Cyclopentolate—Abdominal distension—Pregabalin—epilepsy syndrome	0.000257	0.00165	CcSEcCtD
Cyclopentolate—Dry mouth—Fosphenytoin—epilepsy syndrome	0.000257	0.00165	CcSEcCtD
Cyclopentolate—Homatropine Methylbromide—CHRM1—epilepsy syndrome	0.000256	0.0452	CrCbGaD
Cyclopentolate—Disorientation—Topiramate—epilepsy syndrome	0.000255	0.00164	CcSEcCtD
Cyclopentolate—Ataxia—Gabapentin—epilepsy syndrome	0.000255	0.00164	CcSEcCtD
Cyclopentolate—Vision blurred—Clonazepam—epilepsy syndrome	0.000255	0.00164	CcSEcCtD
Cyclopentolate—Tremor—Clonazepam—epilepsy syndrome	0.000254	0.00163	CcSEcCtD
Cyclopentolate—Pruritus—Rufinamide—epilepsy syndrome	0.000253	0.00163	CcSEcCtD
Cyclopentolate—Vertigo—Zonisamide—epilepsy syndrome	0.000252	0.00162	CcSEcCtD
Cyclopentolate—Drowsiness—Valproic Acid—epilepsy syndrome	0.000252	0.00162	CcSEcCtD
Cyclopentolate—Vision blurred—Oxcarbazepine—epilepsy syndrome	0.000252	0.00162	CcSEcCtD
Cyclopentolate—Tremor—Phenytoin—epilepsy syndrome	0.000252	0.00162	CcSEcCtD
Cyclopentolate—Tremor—Oxcarbazepine—epilepsy syndrome	0.000251	0.00161	CcSEcCtD
Cyclopentolate—Pethidine—GRIN2B—epilepsy syndrome	0.00025	0.0442	CrCbGaD
Cyclopentolate—Agitation—Clonazepam—epilepsy syndrome	0.000249	0.0016	CcSEcCtD
Cyclopentolate—Agitation—Phenytoin—epilepsy syndrome	0.000247	0.00159	CcSEcCtD
Cyclopentolate—Atropine—CHRM3—epilepsy syndrome	0.000247	0.0436	CrCbGaD
Cyclopentolate—Dry mouth—Diazepam—epilepsy syndrome	0.000247	0.00159	CcSEcCtD
Cyclopentolate—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000246	0.00158	CcSEcCtD
Cyclopentolate—Agitation—Oxcarbazepine—epilepsy syndrome	0.000246	0.00158	CcSEcCtD
Cyclopentolate—Conjunctivitis—Valproic Acid—epilepsy syndrome	0.000245	0.00158	CcSEcCtD
Cyclopentolate—Convulsion—Zonisamide—epilepsy syndrome	0.000243	0.00156	CcSEcCtD
Cyclopentolate—Vertigo—Clonazepam—epilepsy syndrome	0.000243	0.00156	CcSEcCtD
Cyclopentolate—Vision blurred—Carbamazepine—epilepsy syndrome	0.000242	0.00155	CcSEcCtD
Cyclopentolate—Vertigo—Phenytoin—epilepsy syndrome	0.000242	0.00155	CcSEcCtD
Cyclopentolate—Tremor—Carbamazepine—epilepsy syndrome	0.00024	0.00155	CcSEcCtD
Cyclopentolate—Somnolence—Propofol—epilepsy syndrome	0.00024	0.00154	CcSEcCtD
Cyclopentolate—Vertigo—Oxcarbazepine—epilepsy syndrome	0.00024	0.00154	CcSEcCtD
Cyclopentolate—Dry mouth—Felbamate—epilepsy syndrome	0.000239	0.00154	CcSEcCtD
Cyclopentolate—Pruritus—Lacosamide—epilepsy syndrome	0.000238	0.00153	CcSEcCtD
Cyclopentolate—Tachycardia—Diazepam—epilepsy syndrome	0.000236	0.00152	CcSEcCtD
Cyclopentolate—Agitation—Carbamazepine—epilepsy syndrome	0.000236	0.00152	CcSEcCtD
Cyclopentolate—Somnolence—Midazolam—epilepsy syndrome	0.000235	0.00151	CcSEcCtD
Cyclopentolate—Dry mouth—Zonisamide—epilepsy syndrome	0.000234	0.0015	CcSEcCtD
Cyclopentolate—Vision blurred—Lamotrigine—epilepsy syndrome	0.000234	0.0015	CcSEcCtD
Cyclopentolate—Convulsion—Phenytoin—epilepsy syndrome	0.000233	0.0015	CcSEcCtD
Cyclopentolate—Tremor—Lamotrigine—epilepsy syndrome	0.000232	0.00149	CcSEcCtD
Cyclopentolate—Somnolence—Levetiracetam—epilepsy syndrome	0.000232	0.00149	CcSEcCtD
Cyclopentolate—Convulsion—Oxcarbazepine—epilepsy syndrome	0.000232	0.00149	CcSEcCtD
Cyclopentolate—Pruritus—Clobazam—epilepsy syndrome	0.000231	0.00148	CcSEcCtD
Cyclopentolate—Vertigo—Carbamazepine—epilepsy syndrome	0.000231	0.00148	CcSEcCtD
Cyclopentolate—Atropine—CHRM1—epilepsy syndrome	0.00023	0.0407	CrCbGaD
Cyclopentolate—Rash—Phenobarbital—epilepsy syndrome	0.00023	0.00148	CcSEcCtD
Cyclopentolate—Dermatitis—Phenobarbital—epilepsy syndrome	0.00023	0.00148	CcSEcCtD
Cyclopentolate—Tachycardia—Felbamate—epilepsy syndrome	0.000228	0.00147	CcSEcCtD
Cyclopentolate—Agitation—Lamotrigine—epilepsy syndrome	0.000228	0.00146	CcSEcCtD
Cyclopentolate—Rash—Rufinamide—epilepsy syndrome	0.000226	0.00145	CcSEcCtD
Cyclopentolate—Dermatitis—Rufinamide—epilepsy syndrome	0.000226	0.00145	CcSEcCtD
Cyclopentolate—Dry mouth—Clonazepam—epilepsy syndrome	0.000225	0.00145	CcSEcCtD
Cyclopentolate—Hallucination—Valproic Acid—epilepsy syndrome	0.000225	0.00145	CcSEcCtD
Cyclopentolate—Somnolence—Fosphenytoin—epilepsy syndrome	0.000224	0.00144	CcSEcCtD
Cyclopentolate—Dry mouth—Phenytoin—epilepsy syndrome	0.000224	0.00144	CcSEcCtD
Cyclopentolate—Tachycardia—Zonisamide—epilepsy syndrome	0.000224	0.00144	CcSEcCtD
Cyclopentolate—Psychotic disorder—Topiramate—epilepsy syndrome	0.000223	0.00143	CcSEcCtD
Cyclopentolate—Vertigo—Lamotrigine—epilepsy syndrome	0.000223	0.00143	CcSEcCtD
Cyclopentolate—Dry mouth—Oxcarbazepine—epilepsy syndrome	0.000223	0.00143	CcSEcCtD
Cyclopentolate—Convulsion—Carbamazepine—epilepsy syndrome	0.000222	0.00143	CcSEcCtD
Cyclopentolate—Conjunctivitis—Pregabalin—epilepsy syndrome	0.000222	0.00142	CcSEcCtD
Cyclopentolate—Hyoscyamine—CHRM2—epilepsy syndrome	0.000221	0.0391	CrCbGaD
Cyclopentolate—Somnolence—Vigabatrin—epilepsy syndrome	0.000218	0.0014	CcSEcCtD
Cyclopentolate—Urinary retention—Topiramate—epilepsy syndrome	0.000217	0.00139	CcSEcCtD
Cyclopentolate—Orphenadrine—SCN9A—epilepsy syndrome	0.000217	0.0383	CrCbGaD
Cyclopentolate—Tachycardia—Clonazepam—epilepsy syndrome	0.000216	0.00139	CcSEcCtD
Cyclopentolate—Somnolence—Diazepam—epilepsy syndrome	0.000215	0.00138	CcSEcCtD
Cyclopentolate—Convulsion—Lamotrigine—epilepsy syndrome	0.000215	0.00138	CcSEcCtD
Cyclopentolate—Ataxia—Topiramate—epilepsy syndrome	0.000215	0.00138	CcSEcCtD
Cyclopentolate—Tachycardia—Phenytoin—epilepsy syndrome	0.000214	0.00138	CcSEcCtD
Cyclopentolate—Dry mouth—Carbamazepine—epilepsy syndrome	0.000214	0.00137	CcSEcCtD
Cyclopentolate—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000213	0.00137	CcSEcCtD
Cyclopentolate—Rash—Lacosamide—epilepsy syndrome	0.000212	0.00136	CcSEcCtD
Cyclopentolate—Dermatitis—Lacosamide—epilepsy syndrome	0.000212	0.00136	CcSEcCtD
Cyclopentolate—Drowsiness—Gabapentin—epilepsy syndrome	0.000209	0.00134	CcSEcCtD
Cyclopentolate—Homatropine Methylbromide—CHRM2—epilepsy syndrome	0.000209	0.0369	CrCbGaD
Cyclopentolate—Venlafaxine—ABCG2—epilepsy syndrome	0.000208	0.0368	CrCbGaD
Cyclopentolate—Somnolence—Felbamate—epilepsy syndrome	0.000208	0.00134	CcSEcCtD
Cyclopentolate—Dry mouth—Lamotrigine—epilepsy syndrome	0.000206	0.00133	CcSEcCtD
Cyclopentolate—Rash—Clobazam—epilepsy syndrome	0.000206	0.00132	CcSEcCtD
Cyclopentolate—Dermatitis—Clobazam—epilepsy syndrome	0.000206	0.00132	CcSEcCtD
Cyclopentolate—Tachycardia—Carbamazepine—epilepsy syndrome	0.000204	0.00131	CcSEcCtD
Cyclopentolate—Somnolence—Zonisamide—epilepsy syndrome	0.000204	0.00131	CcSEcCtD
Cyclopentolate—Hallucination—Pregabalin—epilepsy syndrome	0.000204	0.00131	CcSEcCtD
Cyclopentolate—Conjunctivitis—Gabapentin—epilepsy syndrome	0.000203	0.00131	CcSEcCtD
Cyclopentolate—Orphenadrine—SCN4A—epilepsy syndrome	0.000199	0.0352	CrCbGaD
Cyclopentolate—Abdominal distension—Topiramate—epilepsy syndrome	0.000199	0.00128	CcSEcCtD
Cyclopentolate—Tachycardia—Lamotrigine—epilepsy syndrome	0.000198	0.00127	CcSEcCtD
Cyclopentolate—Somnolence—Clonazepam—epilepsy syndrome	0.000196	0.00126	CcSEcCtD
Cyclopentolate—Somnolence—Phenytoin—epilepsy syndrome	0.000195	0.00125	CcSEcCtD
Cyclopentolate—Somnolence—Oxcarbazepine—epilepsy syndrome	0.000194	0.00125	CcSEcCtD
Cyclopentolate—Pruritus—Propofol—epilepsy syndrome	0.000191	0.00123	CcSEcCtD
Cyclopentolate—Flushing—Pregabalin—epilepsy syndrome	0.00019	0.00122	CcSEcCtD
Cyclopentolate—Atropine—CHRM2—epilepsy syndrome	0.000188	0.0332	CrCbGaD
Cyclopentolate—Pruritus—Midazolam—epilepsy syndrome	0.000187	0.0012	CcSEcCtD
Cyclopentolate—Hallucination—Gabapentin—epilepsy syndrome	0.000187	0.0012	CcSEcCtD
Cyclopentolate—Somnolence—Carbamazepine—epilepsy syndrome	0.000186	0.0012	CcSEcCtD
Cyclopentolate—Vision blurred—Valproic Acid—epilepsy syndrome	0.000186	0.00119	CcSEcCtD
Cyclopentolate—Pruritus—Levetiracetam—epilepsy syndrome	0.000185	0.00119	CcSEcCtD
Cyclopentolate—Tremor—Valproic Acid—epilepsy syndrome	0.000185	0.00119	CcSEcCtD
Cyclopentolate—Agitation—Valproic Acid—epilepsy syndrome	0.000181	0.00116	CcSEcCtD
Cyclopentolate—Somnolence—Lamotrigine—epilepsy syndrome	0.00018	0.00116	CcSEcCtD
Cyclopentolate—Pruritus—Fosphenytoin—epilepsy syndrome	0.000178	0.00115	CcSEcCtD
Cyclopentolate—Vertigo—Valproic Acid—epilepsy syndrome	0.000177	0.00114	CcSEcCtD
Cyclopentolate—Dexmethylphenidate—SLC6A4—epilepsy syndrome	0.000175	0.0309	CrCbGaD
Cyclopentolate—Methylphenidate—SLC6A4—epilepsy syndrome	0.000175	0.0309	CrCbGaD
Cyclopentolate—Pruritus—Vigabatrin—epilepsy syndrome	0.000174	0.00112	CcSEcCtD
Cyclopentolate—Venlafaxine—SLC6A4—epilepsy syndrome	0.000173	0.0305	CrCbGaD
Cyclopentolate—Pruritus—Diazepam—epilepsy syndrome	0.000171	0.0011	CcSEcCtD
Cyclopentolate—Conjunctivitis—Topiramate—epilepsy syndrome	0.000171	0.0011	CcSEcCtD
Cyclopentolate—Rash—Propofol—epilepsy syndrome	0.00017	0.0011	CcSEcCtD
Cyclopentolate—Dermatitis—Propofol—epilepsy syndrome	0.00017	0.00109	CcSEcCtD
Cyclopentolate—Vision blurred—Pregabalin—epilepsy syndrome	0.000168	0.00108	CcSEcCtD
Cyclopentolate—Tremor—Pregabalin—epilepsy syndrome	0.000167	0.00107	CcSEcCtD
Cyclopentolate—Rash—Midazolam—epilepsy syndrome	0.000167	0.00107	CcSEcCtD
Cyclopentolate—Dermatitis—Midazolam—epilepsy syndrome	0.000167	0.00107	CcSEcCtD
Cyclopentolate—Pruritus—Felbamate—epilepsy syndrome	0.000166	0.00106	CcSEcCtD
Cyclopentolate—Rash—Levetiracetam—epilepsy syndrome	0.000165	0.00106	CcSEcCtD
Cyclopentolate—Dermatitis—Levetiracetam—epilepsy syndrome	0.000165	0.00106	CcSEcCtD
Cyclopentolate—Dry mouth—Valproic Acid—epilepsy syndrome	0.000164	0.00105	CcSEcCtD
Cyclopentolate—Agitation—Pregabalin—epilepsy syndrome	0.000164	0.00105	CcSEcCtD
Cyclopentolate—Venlafaxine—CYP2C19—epilepsy syndrome	0.000164	0.0289	CrCbGaD
Cyclopentolate—Pruritus—Zonisamide—epilepsy syndrome	0.000162	0.00104	CcSEcCtD
Cyclopentolate—Pethidine—OPRM1—epilepsy syndrome	0.00016	0.0283	CrCbGaD
Cyclopentolate—Vertigo—Pregabalin—epilepsy syndrome	0.00016	0.00103	CcSEcCtD
Cyclopentolate—Rash—Fosphenytoin—epilepsy syndrome	0.000159	0.00102	CcSEcCtD
Cyclopentolate—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000159	0.00102	CcSEcCtD
Cyclopentolate—Hallucination—Topiramate—epilepsy syndrome	0.000157	0.00101	CcSEcCtD
Cyclopentolate—Tachycardia—Valproic Acid—epilepsy syndrome	0.000157	0.00101	CcSEcCtD
Cyclopentolate—Pruritus—Clonazepam—epilepsy syndrome	0.000156	0.001	CcSEcCtD
Cyclopentolate—Pruritus—Phenytoin—epilepsy syndrome	0.000155	0.000998	CcSEcCtD
Cyclopentolate—Rash—Vigabatrin—epilepsy syndrome	0.000155	0.000996	CcSEcCtD
Cyclopentolate—Dermatitis—Vigabatrin—epilepsy syndrome	0.000155	0.000995	CcSEcCtD
Cyclopentolate—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000154	0.000992	CcSEcCtD
Cyclopentolate—Convulsion—Pregabalin—epilepsy syndrome	0.000154	0.000992	CcSEcCtD
Cyclopentolate—Vision blurred—Gabapentin—epilepsy syndrome	0.000154	0.00099	CcSEcCtD
Cyclopentolate—Tremor—Gabapentin—epilepsy syndrome	0.000153	0.000984	CcSEcCtD
Cyclopentolate—Rash—Diazepam—epilepsy syndrome	0.000153	0.00098	CcSEcCtD
Cyclopentolate—Dermatitis—Diazepam—epilepsy syndrome	0.000152	0.000979	CcSEcCtD
Cyclopentolate—Agitation—Gabapentin—epilepsy syndrome	0.00015	0.000965	CcSEcCtD
Cyclopentolate—Dry mouth—Pregabalin—epilepsy syndrome	0.000148	0.000953	CcSEcCtD
Cyclopentolate—Pruritus—Carbamazepine—epilepsy syndrome	0.000148	0.000952	CcSEcCtD
Cyclopentolate—Rash—Felbamate—epilepsy syndrome	0.000148	0.000949	CcSEcCtD
Cyclopentolate—Dermatitis—Felbamate—epilepsy syndrome	0.000147	0.000948	CcSEcCtD
Cyclopentolate—Vertigo—Gabapentin—epilepsy syndrome	0.000147	0.000943	CcSEcCtD
Cyclopentolate—Flushing—Topiramate—epilepsy syndrome	0.000147	0.000942	CcSEcCtD
Cyclopentolate—Orphenadrine—SCN1A—epilepsy syndrome	0.000146	0.0257	CrCbGaD
Cyclopentolate—Rash—Zonisamide—epilepsy syndrome	0.000144	0.000929	CcSEcCtD
Cyclopentolate—Dermatitis—Zonisamide—epilepsy syndrome	0.000144	0.000928	CcSEcCtD
Cyclopentolate—Pruritus—Lamotrigine—epilepsy syndrome	0.000143	0.00092	CcSEcCtD
Cyclopentolate—Somnolence—Valproic Acid—epilepsy syndrome	0.000143	0.000919	CcSEcCtD
Cyclopentolate—Tachycardia—Pregabalin—epilepsy syndrome	0.000142	0.000912	CcSEcCtD
Cyclopentolate—Convulsion—Gabapentin—epilepsy syndrome	0.000142	0.00091	CcSEcCtD
Cyclopentolate—Rash—Clonazepam—epilepsy syndrome	0.000139	0.000895	CcSEcCtD
Cyclopentolate—Dermatitis—Clonazepam—epilepsy syndrome	0.000139	0.000894	CcSEcCtD
Cyclopentolate—Rash—Phenytoin—epilepsy syndrome	0.000138	0.000889	CcSEcCtD
Cyclopentolate—Dermatitis—Phenytoin—epilepsy syndrome	0.000138	0.000888	CcSEcCtD
Cyclopentolate—Rash—Oxcarbazepine—epilepsy syndrome	0.000138	0.000884	CcSEcCtD
Cyclopentolate—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000137	0.000884	CcSEcCtD
Cyclopentolate—Dry mouth—Gabapentin—epilepsy syndrome	0.000136	0.000874	CcSEcCtD
Cyclopentolate—Rash—Carbamazepine—epilepsy syndrome	0.000132	0.000849	CcSEcCtD
Cyclopentolate—Dermatitis—Carbamazepine—epilepsy syndrome	0.000132	0.000848	CcSEcCtD
Cyclopentolate—Tachycardia—Gabapentin—epilepsy syndrome	0.00013	0.000836	CcSEcCtD
Cyclopentolate—Vision blurred—Topiramate—epilepsy syndrome	0.00013	0.000833	CcSEcCtD
Cyclopentolate—Somnolence—Pregabalin—epilepsy syndrome	0.000129	0.000831	CcSEcCtD
Cyclopentolate—CHRM1—forebrain—epilepsy syndrome	0.000129	0.0767	CbGeAlD
Cyclopentolate—Tremor—Topiramate—epilepsy syndrome	0.000129	0.000828	CcSEcCtD
Cyclopentolate—Rash—Lamotrigine—epilepsy syndrome	0.000128	0.00082	CcSEcCtD
Cyclopentolate—Dermatitis—Lamotrigine—epilepsy syndrome	0.000127	0.00082	CcSEcCtD
Cyclopentolate—Agitation—Topiramate—epilepsy syndrome	0.000126	0.000812	CcSEcCtD
Cyclopentolate—Vertigo—Topiramate—epilepsy syndrome	0.000123	0.000794	CcSEcCtD
Cyclopentolate—Methylphenidate—CYP2D6—epilepsy syndrome	0.000123	0.0217	CrCbGaD
Cyclopentolate—Dexmethylphenidate—CYP2D6—epilepsy syndrome	0.000123	0.0217	CrCbGaD
Cyclopentolate—Venlafaxine—CYP2D6—epilepsy syndrome	0.000121	0.0214	CrCbGaD
Cyclopentolate—Convulsion—Topiramate—epilepsy syndrome	0.000119	0.000765	CcSEcCtD
Cyclopentolate—Somnolence—Gabapentin—epilepsy syndrome	0.000119	0.000762	CcSEcCtD
Cyclopentolate—CHRM1—telencephalon—epilepsy syndrome	0.000118	0.0705	CbGeAlD
Cyclopentolate—CHRM3—forebrain—epilepsy syndrome	0.000115	0.0686	CbGeAlD
Cyclopentolate—Dry mouth—Topiramate—epilepsy syndrome	0.000114	0.000736	CcSEcCtD
Cyclopentolate—Pruritus—Valproic Acid—epilepsy syndrome	0.000114	0.000731	CcSEcCtD
Cyclopentolate—Tachycardia—Topiramate—epilepsy syndrome	0.000109	0.000704	CcSEcCtD
Cyclopentolate—CHRM3—telencephalon—epilepsy syndrome	0.000106	0.0631	CbGeAlD
Cyclopentolate—Pruritus—Pregabalin—epilepsy syndrome	0.000103	0.000661	CcSEcCtD
Cyclopentolate—Rash—Valproic Acid—epilepsy syndrome	0.000101	0.000652	CcSEcCtD
Cyclopentolate—Dermatitis—Valproic Acid—epilepsy syndrome	0.000101	0.000651	CcSEcCtD
Cyclopentolate—Somnolence—Topiramate—epilepsy syndrome	9.97e-05	0.000641	CcSEcCtD
Cyclopentolate—BCHE—brainstem—epilepsy syndrome	9.75e-05	0.058	CbGeAlD
Cyclopentolate—Pruritus—Gabapentin—epilepsy syndrome	9.43e-05	0.000606	CcSEcCtD
Cyclopentolate—BCHE—forebrain—epilepsy syndrome	9.41e-05	0.056	CbGeAlD
Cyclopentolate—Rash—Pregabalin—epilepsy syndrome	9.17e-05	0.000589	CcSEcCtD
Cyclopentolate—Dermatitis—Pregabalin—epilepsy syndrome	9.16e-05	0.000589	CcSEcCtD
Cyclopentolate—Pethidine—SLC6A4—epilepsy syndrome	8.84e-05	0.0156	CrCbGaD
Cyclopentolate—Venlafaxine—ABCB1—epilepsy syndrome	8.66e-05	0.0153	CrCbGaD
Cyclopentolate—BCHE—telencephalon—epilepsy syndrome	8.65e-05	0.0515	CbGeAlD
Cyclopentolate—Rash—Gabapentin—epilepsy syndrome	8.41e-05	0.00054	CcSEcCtD
Cyclopentolate—Dermatitis—Gabapentin—epilepsy syndrome	8.4e-05	0.00054	CcSEcCtD
Cyclopentolate—Pethidine—CYP2C19—epilepsy syndrome	8.38e-05	0.0148	CrCbGaD
Cyclopentolate—Pruritus—Topiramate—epilepsy syndrome	7.94e-05	0.00051	CcSEcCtD
Cyclopentolate—Diphenhydramine—CHRM2—epilepsy syndrome	7.83e-05	0.0138	CrCbGaD
Cyclopentolate—Orphenadrine—CHRM2—epilepsy syndrome	7.41e-05	0.0131	CrCbGaD
Cyclopentolate—CHRM1—head—epilepsy syndrome	7.37e-05	0.0439	CbGeAlD
Cyclopentolate—Rash—Topiramate—epilepsy syndrome	7.07e-05	0.000455	CcSEcCtD
Cyclopentolate—Dermatitis—Topiramate—epilepsy syndrome	7.07e-05	0.000454	CcSEcCtD
Cyclopentolate—CHRM1—nervous system—epilepsy syndrome	6.99e-05	0.0416	CbGeAlD
Cyclopentolate—BCHE—medulla oblongata—epilepsy syndrome	6.8e-05	0.0405	CbGeAlD
Cyclopentolate—CHRM1—central nervous system—epilepsy syndrome	6.73e-05	0.0401	CbGeAlD
Cyclopentolate—CHRM3—head—epilepsy syndrome	6.6e-05	0.0393	CbGeAlD
Cyclopentolate—CHRM3—nervous system—epilepsy syndrome	6.26e-05	0.0373	CbGeAlD
Cyclopentolate—BCHE—midbrain—epilepsy syndrome	6.21e-05	0.037	CbGeAlD
Cyclopentolate—Pethidine—CYP2D6—epilepsy syndrome	6.21e-05	0.011	CrCbGaD
Cyclopentolate—BCHE—spinal cord—epilepsy syndrome	6.06e-05	0.0361	CbGeAlD
Cyclopentolate—CHRM3—central nervous system—epilepsy syndrome	6.02e-05	0.0359	CbGeAlD
Cyclopentolate—BCHE—head—epilepsy syndrome	5.39e-05	0.0321	CbGeAlD
Cyclopentolate—CHRM1—brain—epilepsy syndrome	5.34e-05	0.0318	CbGeAlD
Cyclopentolate—BCHE—nervous system—epilepsy syndrome	5.11e-05	0.0304	CbGeAlD
Cyclopentolate—BCHE—central nervous system—epilepsy syndrome	4.92e-05	0.0293	CbGeAlD
Cyclopentolate—Diphenhydramine—CYP2C19—epilepsy syndrome	4.83e-05	0.00854	CrCbGaD
Cyclopentolate—BCHE—cerebellum—epilepsy syndrome	4.81e-05	0.0286	CbGeAlD
Cyclopentolate—CHRM3—brain—epilepsy syndrome	4.78e-05	0.0285	CbGeAlD
Cyclopentolate—Pethidine—ALB—epilepsy syndrome	4.65e-05	0.00821	CrCbGaD
Cyclopentolate—BCHE—brain—epilepsy syndrome	3.9e-05	0.0232	CbGeAlD
Cyclopentolate—Diphenhydramine—CYP2D6—epilepsy syndrome	3.58e-05	0.00633	CrCbGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.84e-05	0.000257	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.84e-05	0.000256	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GRM8—epilepsy syndrome	1.82e-05	0.000254	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PGF—epilepsy syndrome	1.82e-05	0.000254	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CCR2—epilepsy syndrome	1.82e-05	0.000254	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—SST—epilepsy syndrome	1.82e-05	0.000254	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GRM8—epilepsy syndrome	1.82e-05	0.000253	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PGF—epilepsy syndrome	1.82e-05	0.000253	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CCR2—epilepsy syndrome	1.81e-05	0.000253	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—SST—epilepsy syndrome	1.81e-05	0.000253	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—HTR7—epilepsy syndrome	1.8e-05	0.000251	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—HTR7—epilepsy syndrome	1.8e-05	0.000251	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—POMC—epilepsy syndrome	1.78e-05	0.000249	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.78e-05	0.000248	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—POMC—epilepsy syndrome	1.78e-05	0.000248	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.77e-05	0.000247	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—CCL2—epilepsy syndrome	1.75e-05	0.000243	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—CCL2—epilepsy syndrome	1.74e-05	0.000243	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—OPRD1—epilepsy syndrome	1.74e-05	0.000242	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GNAO1—epilepsy syndrome	1.74e-05	0.000242	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—OPRD1—epilepsy syndrome	1.73e-05	0.000242	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GNAO1—epilepsy syndrome	1.73e-05	0.000242	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AKT3—epilepsy syndrome	1.72e-05	0.00024	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.72e-05	0.000239	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AKT3—epilepsy syndrome	1.71e-05	0.000239	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CYP2D6—epilepsy syndrome	1.71e-05	0.000239	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CXCL12—epilepsy syndrome	1.71e-05	0.000238	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.71e-05	0.000238	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.7e-05	0.000238	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CXCL12—epilepsy syndrome	1.7e-05	0.000238	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CNR1—epilepsy syndrome	1.68e-05	0.000234	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CNR1—epilepsy syndrome	1.67e-05	0.000233	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PLCB1—epilepsy syndrome	1.67e-05	0.000233	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GRM1—epilepsy syndrome	1.67e-05	0.000232	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCR7—epilepsy syndrome	1.67e-05	0.000232	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PDYN—epilepsy syndrome	1.67e-05	0.000232	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PLCB1—epilepsy syndrome	1.67e-05	0.000232	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PDYN—epilepsy syndrome	1.66e-05	0.000232	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCR7—epilepsy syndrome	1.66e-05	0.000232	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GRM1—epilepsy syndrome	1.66e-05	0.000232	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CHRM1—epilepsy syndrome	1.66e-05	0.000232	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HTR7—epilepsy syndrome	1.64e-05	0.000228	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HTR7—epilepsy syndrome	1.63e-05	0.000228	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ADRA2A—epilepsy syndrome	1.63e-05	0.000227	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—POMC—epilepsy syndrome	1.63e-05	0.000227	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—CCL2—epilepsy syndrome	1.59e-05	0.000222	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HBEGF—epilepsy syndrome	1.59e-05	0.000222	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HBEGF—epilepsy syndrome	1.58e-05	0.000221	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—CDC42—epilepsy syndrome	1.57e-05	0.000219	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GAL—epilepsy syndrome	1.57e-05	0.000219	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GFAP—epilepsy syndrome	1.57e-05	0.000219	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—CDC42—epilepsy syndrome	1.56e-05	0.000218	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GFAP—epilepsy syndrome	1.56e-05	0.000218	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GAL—epilepsy syndrome	1.56e-05	0.000218	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AKT3—epilepsy syndrome	1.56e-05	0.000218	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AKT3—epilepsy syndrome	1.56e-05	0.000217	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CASP2—epilepsy syndrome	1.55e-05	0.000216	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CHRM3—epilepsy syndrome	1.55e-05	0.000216	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GRM5—epilepsy syndrome	1.55e-05	0.000216	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—SLC2A1—epilepsy syndrome	1.55e-05	0.000216	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GRM5—epilepsy syndrome	1.55e-05	0.000215	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CASP2—epilepsy syndrome	1.55e-05	0.000215	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PLCB1—epilepsy syndrome	1.53e-05	0.000214	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—TH—epilepsy syndrome	1.53e-05	0.000213	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AVP—epilepsy syndrome	1.52e-05	0.000212	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AVP—epilepsy syndrome	1.51e-05	0.000211	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ABCG2—epilepsy syndrome	1.51e-05	0.00021	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.5e-05	0.000209	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.49e-05	0.000207	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CX3CR1—epilepsy syndrome	1.48e-05	0.000207	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP2C19—epilepsy syndrome	1.47e-05	0.000205	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP11A1—epilepsy syndrome	1.46e-05	0.000203	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.46e-05	0.000203	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CHRM2—epilepsy syndrome	1.46e-05	0.000203	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.46e-05	0.000203	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CX3CL1—epilepsy syndrome	1.45e-05	0.000203	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CHRM2—epilepsy syndrome	1.45e-05	0.000203	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—BDKRB1—epilepsy syndrome	1.45e-05	0.000203	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CDC42—epilepsy syndrome	1.42e-05	0.000199	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CDC42—epilepsy syndrome	1.42e-05	0.000198	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GABBR1—epilepsy syndrome	1.42e-05	0.000198	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GABBR1—epilepsy syndrome	1.41e-05	0.000197	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AVP—epilepsy syndrome	1.38e-05	0.000192	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AVP—epilepsy syndrome	1.37e-05	0.000192	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HRH3—epilepsy syndrome	1.36e-05	0.00019	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HRH3—epilepsy syndrome	1.35e-05	0.000189	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—OPRM1—epilepsy syndrome	1.34e-05	0.000187	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—OPRM1—epilepsy syndrome	1.33e-05	0.000186	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP2D6—epilepsy syndrome	1.32e-05	0.000184	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.29e-05	0.00018	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—CCR5—epilepsy syndrome	1.29e-05	0.000179	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—HMOX1—epilepsy syndrome	1.27e-05	0.000178	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.26e-05	0.000176	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.26e-05	0.000176	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	1.26e-05	0.000176	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.26e-05	0.000176	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CAT—epilepsy syndrome	1.26e-05	0.000175	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	1.25e-05	0.000175	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—BCHE—epilepsy syndrome	1.25e-05	0.000174	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	1.23e-05	0.000172	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.23e-05	0.000172	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	1.23e-05	0.000171	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	1.23e-05	0.000171	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ABCB1—epilepsy syndrome	1.22e-05	0.00017	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	1.2e-05	0.000167	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	1.19e-05	0.000167	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	1.19e-05	0.000166	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	1.19e-05	0.000166	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	1.19e-05	0.000166	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	1.19e-05	0.000166	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	1.19e-05	0.000166	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	1.19e-05	0.000166	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	1.18e-05	0.000165	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	1.18e-05	0.000165	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	1.18e-05	0.000165	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	1.18e-05	0.000165	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	1.18e-05	0.000165	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PLCB1—epilepsy syndrome	1.18e-05	0.000164	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—TH—epilepsy syndrome	1.17e-05	0.000164	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	1.17e-05	0.000163	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	1.17e-05	0.000163	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.15e-05	0.00016	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	1.14e-05	0.000159	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GPX1—epilepsy syndrome	1.14e-05	0.000158	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.11e-05	0.000154	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	1.1e-05	0.000154	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	1.1e-05	0.000154	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.1e-05	0.000154	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	1.1e-05	0.000154	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	1.1e-05	0.000154	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	1.09e-05	0.000152	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	1.08e-05	0.000151	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	1.07e-05	0.00015	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SST—epilepsy syndrome	1.07e-05	0.00015	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	1.07e-05	0.00015	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	1.07e-05	0.000149	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	1.07e-05	0.000149	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SST—epilepsy syndrome	1.07e-05	0.000149	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	1.07e-05	0.000148	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	1.06e-05	0.000148	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.05e-05	0.000147	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	1.05e-05	0.000146	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	1.05e-05	0.000146	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	1.04e-05	0.000146	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.01e-05	0.000141	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	1.01e-05	0.000141	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	1.01e-05	0.000141	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	1.01e-05	0.00014	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	1.01e-05	0.00014	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.01e-05	0.00014	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	1.01e-05	0.00014	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	1e-05	0.00014	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	1e-05	0.00014	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	9.98e-06	0.000139	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—AGT—epilepsy syndrome	9.97e-06	0.000139	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	9.92e-06	0.000138	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	9.92e-06	0.000138	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	9.88e-06	0.000138	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	9.88e-06	0.000138	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	9.88e-06	0.000138	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	9.85e-06	0.000137	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—HMOX1—epilepsy syndrome	9.8e-06	0.000137	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—APOE—epilepsy syndrome	9.77e-06	0.000136	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	9.67e-06	0.000135	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CAT—epilepsy syndrome	9.66e-06	0.000135	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	9.64e-06	0.000134	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ABCB1—epilepsy syndrome	9.4e-06	0.000131	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	9.39e-06	0.000131	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	9.36e-06	0.000131	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	9.22e-06	0.000129	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	9.19e-06	0.000128	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	9.16e-06	0.000128	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	9.13e-06	0.000127	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	9e-06	0.000126	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	8.98e-06	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	8.96e-06	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	8.93e-06	0.000125	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GPX1—epilepsy syndrome	8.74e-06	0.000122	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	8.51e-06	0.000119	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	8.49e-06	0.000118	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	8.43e-06	0.000118	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	8.41e-06	0.000117	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	8.4e-06	0.000117	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—POMC—epilepsy syndrome	8.39e-06	0.000117	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	8.38e-06	0.000117	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	8.14e-06	0.000114	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	8.12e-06	0.000113	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	7.7e-06	0.000107	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	7.68e-06	0.000107	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—AGT—epilepsy syndrome	7.66e-06	0.000107	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ALB—epilepsy syndrome	7.65e-06	0.000107	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOE—epilepsy syndrome	7.51e-06	0.000105	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	7.49e-06	0.000104	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	7.46e-06	0.000104	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	7.46e-06	0.000104	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	7.45e-06	0.000104	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	7.44e-06	0.000104	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	7.42e-06	0.000104	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	7.2e-06	0.0001	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	7.18e-06	0.0001	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	7.12e-06	9.92e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	7.09e-06	9.89e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	6.92e-06	9.65e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	6.9e-06	9.62e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	6.78e-06	9.45e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	6.75e-06	9.42e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PTGS2—epilepsy syndrome	6.69e-06	9.33e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—POMC—epilepsy syndrome	6.45e-06	8.99e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	6.44e-06	8.97e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	6.43e-06	8.96e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	6.42e-06	8.95e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	6.41e-06	8.93e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	6.3e-06	8.78e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	6.28e-06	8.75e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	6.17e-06	8.6e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	6.15e-06	8.58e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	5.94e-06	8.28e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	5.92e-06	8.26e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	5.92e-06	8.25e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	5.9e-06	8.22e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ALB—epilepsy syndrome	5.88e-06	8.2e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	5.41e-06	7.54e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	5.39e-06	7.52e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	5.29e-06	7.38e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	5.28e-06	7.36e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PTGS2—epilepsy syndrome	5.15e-06	7.17e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	4.79e-06	6.67e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	4.77e-06	6.65e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	4.44e-06	6.19e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	4.43e-06	6.17e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	4.36e-06	6.07e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	4.34e-06	6.05e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.04e-06	5.64e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	4.03e-06	5.62e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	4.01e-06	5.59e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	3.99e-06	5.57e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	3.89e-06	5.43e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	3.88e-06	5.41e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	3.79e-06	5.28e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	3.77e-06	5.26e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	3.67e-06	5.12e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	3.66e-06	5.1e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	3.49e-06	4.87e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	3.48e-06	4.85e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	3.4e-06	4.74e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	3.39e-06	4.72e-05	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—AKT1—epilepsy syndrome	3.36e-06	4.69e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—AKT1—epilepsy syndrome	2.59e-06	3.61e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	2.17e-06	3.02e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	2.16e-06	3.01e-05	CbGpPWpGaD
